HK Stock MarketDetailed Quotes

00570 TRAD CHI MED

Watchlist
  • 2.190
  • +0.010+0.46%
Market Closed Nov 26 16:08 CST
11.03BMarket Cap10.95P/E (TTM)

About TRAD CHI MED Company

China Traditional Chinese Medicine Holdings Co., Ltd. (“Chinese Traditional Chinese Medicine”) is the core platform for the Chinese medicine industry sector of China Pharmaceutical Group Co., Ltd. (“Sinopharm Group”). The company is listed on the main board of the Hong Kong Stock Exchange (stock code: 00570.HK), and its headquarters management center is located in Foshan, Guangdong. The company employs about 18,000 people and has over 100 subsidiaries. The company has a complete industrial chain, integrating scientific research, manufacturing and sales. It has more than 800 finished drug regulations (of which more than 280 product regulations were selected for the 2018 edition of the “National Essential Medicines Catalogue”), more than 700 varieties of single-flavor traditional Chinese medicine formula granules, and more than 400 classic compound concentrated granules (exclusively for export). It covers fields related to the cultivation of Chinese herbal medicines, traditional Chinese medicine tablets, formula granules, proprietary Chinese medicine, traditional Chinese medicine and health. Chinese traditional Chinese medicine brings together the essence of traditional Chinese medicine, spans more than 400 years of history, and inherits the five famous trademarks of “Liang Zhonghong Lavan”, “Feng Liangsheng”, “Tongjitang”, and “Yuanjitang”, and “Yuanjitang”. It has three time-honored Chinese brands, “Fairy Ling”, “Tongjitang”, “Fairy Bone Bao”, “Tianjiang Pharmaceutical”, and “German Zhong”, “Tongjitang”, “Tongjitang”, and “Chinese Medicine Culture” The four intangible cultural heritages of “Feng Liao's Rheumatism Medicated Liquor”, “Shaolin Pain Relief Cream”, and “Yuanji Gan He Tea”, as well as “Xianling Bone Bao Capsule” and “Neck Relief” “Granules,” “Rheumatoid Bone Pain Capsules,” “Seven Centigrade Capsules,” “Moisturizing and Itching Capsules,” “Zao Kernel Anshen Capsules,” “Yu Pingfeng Granules,” “Rhinitis Health Tablets,” “Golden Leaf Detox Granules,” and “Turtle Family Decontamination Pills” are the top 10 nationally exclusive essential medicines. Chinese traditional Chinese medicine has always insisted on quality as the core, has high-quality brands and product resources, and has won the trust of doctors and patients! With the mission of “implementing the national traditional Chinese medicine development strategy and leading the high-quality development of the traditional Chinese medicine industry”, the company will vigorously develop the herbal medicine resource industry with industry as the lead, science and technology as support, give full play to traditional trade advantages, actively enter the field of traditional Chinese medicine value-added health services, share the 10 billion traditional Chinese medicine platform with all sectors, and become a leader in the traditional Chinese medicine industry! Announcement on December 25, 2018: Wang Xiaochun assumed the position of president. Announcement on September 10, 2021: Wang Xiaochun was removed from the post of President. May 23, 2022 Announcement: Chen Yinglong will serve as Chairman of the Board of Directors. Announcement on March 26, 2024: Chen Yinglong will act as president.

Company Profile

Symbol00570
Company NameTRAD CHI MED
ISINHK0000056256
Listing DateApr 7, 1993
Issue Price1.02
Shares Offered45.00M share(s)
FoundedJul 23, 1992
Registered AddressHong Kong, China
Chairmanjun yang
Secretarydongjiwuxiuwei zhao
Audit InstitutionErnst & Young
Company CategoryOverseas registration of Mainland State-owned Assets control
Registered OfficeRoom 1601, King's Group Centre, 288 Hennessy Road, Wan Chai, Hong Kong, China
Head Office and Principal Place of BusinessRoom 1601, Emperor Group Centre, 288 Hennessy Road, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees17716
MarketHong Kong motherboard
Phone(852)28543393
Fax(852)25441269
Emailpublicrelation@china-tcm.com.cn
Business China Traditional Chinese Medicine Holdings Co., Ltd. is the core platform for the modern traditional Chinese medicine sector of China Pharmaceutical Group Co., Ltd. The company is listed on Red Chip on the main board of the Hong Kong Stock Exchange (stock code: 00570.HK). The headquarters management center is located in Foshan, Guangdong, employs about 18,000 people, and has over 100 subsidiaries in more than 20 provinces and cities across the country. Adhering to the mission of “implementing the national traditional Chinese medicine development strategy and leading the high-quality development of the traditional Chinese medicine industry”, the company's business covers the production and operation of Chinese herbal medicines, traditional Chinese medicine tablets, traditional Chinese medicine formula particles, proprietary Chinese medicine, health products of traditional Chinese medicine, and the National Medical Center. It has built the largest Chinese medicine industry manufacturing industry cluster in the country. At present, it has built a number of national firsts: the layout of the Chinese herbal medicine base and initial processing capacity in the country; the “shared traditional Chinese medicine · intelligent distribution center model” business model of Chinese medicine tablets is number one in the country; the Chinese medicine tablet “shared traditional Chinese medicine · intelligent distribution center model” business model is number one in the country; the Chinese medicine tablet “shared traditional Chinese medicine · intelligent distribution center model” business model is number one in the country; the Chinese medicine tablet “shared traditional Chinese medicine · intelligent distribution center model” business model is number one in the country; the Chinese medicine tablet “shared traditional Chinese medicine · intelligent distribution center model” business model is number one in the country; the Chinese medicine tablet “shared Chinese medicine · intelligent distribution center model” business model is number one Highest capacity and market size in the country; proprietary Chinese medicine base The number of drugs, product ranks, and production capacity are the highest in the country.

Company Executives

  • Name
  • Position
  • Salary
  • jun yang
  • Chairman of the Board, Executive Director, Chairman of the Nomination Committee, Chairman of the Strategy Committee, Authorized Representative
  • --
  • hongjian li
  • President, Executive Director, Strategy Committee Member, Nomination Committee Members
  • --
  • xueren cheng
  • Non-executive Directors, Strategy Committee Members
  • 2.49M
  • wenming yang
  • Non-executive Directors, Party Secretary, Strategy Committee Members
  • 2.60M
  • ru li
  • Non-executive Directors
  • --
  • binghua yang
  • Non-executive Directors, Nomination Committee Members
  • --
  • kan wang
  • Non-executive Directors
  • --
  • qingxin meng
  • Non-executive Directors
  • --
  • rong xie
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members, Nomination Committee Members
  • 279.00K
  • zishan yu
  • Independent Non-Executive Director, Nomination Committee Members, Remuneration Committee Members, Audit Committee Members, Strategy Committee Members
  • 279.00K
  • ling qin
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Strategy Committee Members, Nomination Committee Members
  • 279.00K
  • weidong li
  • Independent Non-Executive Director, Audit Committee Members, Nomination Committee Members, Remuneration Committee Members
  • 279.00K
  • lixin shen
  • VP, Chief Financial Officer
  • --
  • qingshan lan
  • VP
  • --
  • dongji zhao
  • VP, Chief Compliance Officer, Joint Company Secretary, General Counsel, Authorized Representative
  • --
  • zhangxin huang
  • VP
  • --
  • xiuwei wu
  • Joint Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data